Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2003

Jang B-, Muñoz-Najar U, Paik J-, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. J Biol Chem. 2003;278(5):2773-6.

Agnese DM, Abdessalam SF, Burak WE, Magro CM, Pozderac RV, Walker MJ. Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. Surgery. 2003;134(4):542-7; discussion 547-8.

Magro CM, Harman AP, Klinger D, Orosz C, Adams P, Waldman J, et al. Use of C4d as a diagnostic adjunct in lung allograft biopsies. Am J Transplant. 2003;3(9):1143-54.

Moscat J, Diaz-Meco MT. Par-4 keeps the atypical PKCs at bay. Cell Cycle. 2003;2(2):71-2.

Creighton C, Kuick R, Misek DE, Rickman DS, Brichory FM, Rouillard J-, et al. Profiling of pathway-specific changes in gene expression following growth of human cancer cell lines transplanted into mice. Genome Biol. 2003;4(7):R46.

Hinoi T, Loda M, Fearon ER. Silencing of CDX2 expression in colon cancer via a dominant repression pathway. J Biol Chem. 2003;278(45):44608-16.

Li H, Ma X, Moskovits T, Inghirami G, Tsiagbe VK. Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas. Clin Immunol. 2003;107(3):160-9.

Scognamiglio T, Hoda RS, Edgar MA, Hoda SA. The need for vigilance in the pathologic evaluation of sentinel lymph nodes: a report of two illustrative cases. Breast J. 2003;9(5):420-2.

Li Y, Yu W-, Ren J, Chen W, Huang L, Kharbanda S, et al. Heregulin targets gamma-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 oncoprotein. Mol Cancer Res. 2003;1(10):765-75.

Makowski A, Brzostek S, Cohen RN, Hollenberg AN. Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol. 2003;17(2):273-86.